+1-518-618-1030 866 - 552 - 3453 USA-Canada Toll Free

High Unmet Medical Needs in Emerging Economies to Fuel Demand for Pain Management Devices, says TMR

Posted on Dec 21, 2015

The dynamic nature of the global market for pain management devices has set in motion strong competition between players. The top three participants, namely Medtronic Plc, St. Jude Medical Inc., and Boston Scientific Corp. collectively accounted for more than 72% of the overall market in 2014, reports Transparency Market Research (TMR) in a new study. 

These companies boast of superior distribution channels and ample supply capabilities that ensure easy availability of their products, validating their lead in this market. However, a large number of medical device manufacturers are looking to venture into the pain management sector, which is projected to intensify the competition and change the current dynamics in the coming years.



Growing Prevalence of Chronic Medical Conditions Boosts Demand for Pain Management Devices

The growing prevalence of chronic medical conditions, such as diabetes, cancer, obesity, osteo and rheumatoid arthritis, and spinal problems, have increased the incidence of chronic pain in individuals. Various studies suggest more than 20% of the adult population suffers from chronic pain and nearly 10% of the global population gets diagnosed with chronic pain every year.

Around half of the cancer patients, globally, experience severe pain at the time of diagnosis and almost 75% complain of a gradual increase in pain as the disease progresses. Chronic pain has also been experienced after the occurrence of the primary disease in nearly 70% of patients suffering from spinal cord injuries, 28% of multiple sclerosis patients, and 8% of stroke patients. These factors result in a rising need for pain management and, thereby, pain management devices across the world.

The global geriatric population, which requires continuous medical intervention and care, represents a significant portion of patients with chronic illnesses. The increase in this population is also fueling the demand for pain management devices worldwide considerably. However, the increasing concerns regarding the risk associated with the implantation of pain management devices are holding people back from adopting them, limiting their growth to some extent.

Moving forward, the unmet medical needs, together with the escalating disposable income of people in emerging economies, are likely to provide lucrative opportunities to pain management device manufacturers in the coming years.

Demand for Pain Management Devices to Register Rapid Rise in Asia Pacific

According to TMR, the global opportunity in pain management devices is projected to register a healthy rise from US$3.2 bn in 2014 to US$6.3 bn by 2023, expanding at a CAGR of 7.60% during the period from 2015 to 2023. Currently, neurostimulation devices have emerged as the most demanded pain management devices across the world.

North America led the demand for pain management devices in 2014 with a share of nearly 50%. Europe closely followed North America with a share of around 22%. Asia Pacific, however, is expected to report the fastest growth at a CAGR of 10.0% over the forecast period. These pain management devices have found maximum application in neuropathic pain and musculoskeletal pain.

The study presented here is based on a report by Transparency Market Research (TMR) titled Pain Management Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2015 - 2023.”

Key Takeaways:

  • Top three participants collectively accounted for over 72% of the market in 2014
  • Increasing concerns over risks associated with implantation of pain management devices hinder their adoption
  • Global opportunity in pain management devices is likely to reach US$6.3 bn by 2023

The global pain management devices market has been segmented as follows:

By Product Type

  • Electrical Stimulation Devices
    • Transcutaneous Electrical Nerve Stimulation (TENS) Devices
    • Neuromuscular Electrical Stimulation (NMES/EMS) Devices
    • Other Electrical Stimulation Devices (Electrotherapy Devices, Combination Devices, TNS, TMS, etc.)
  • Radiofrequency Ablation Devices
  • Analgesic Infusion Pumps
    • Intrathecal Infusion Pumps
    • External Infusion Pumps
  • Neurostimulation Devices
    • Spinal Cord Stimulation (SCS) Devices
    • Deep Brain Stimulation Devices
    • Vagus Nerve Stimulation Devices
    • Sacral Nerve Stimulation Devices

By Application

  • Electrical Stimulation Devices
    • Neuropathic Pain
    • Cancer Pain
    • Facial & Migraine Pain
    • Musculoskeletal Pain
    • Trauma
  • Neurostimulation Devices
    • Neuropathic Pain
    • Cancer Pain
    • Facial & Migraine Pain
    • Musculoskeletal Pain
  • Analgesic Infusion Pumps
    • Neuropathic Pain
    • Cancer Pain
    • Trauma
    • Musculoskeletal Pain
  • Radiofrequency Ablation Devices
    • Neuropathic Pain
    • Cancer Pain
    • Musculoskeletal Pain

By Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • Rest of Europe
  • Asia Pacific (APAC)
    • China
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Rest of Latin America
  • Middle East & North Africa (MENA)
    • Egypt
    • Saudi Arabia
    • Rest of MENA
  • Rest of the World (RoW)

Browse : Our new press releases http://www.transparencymarketresearch.com/pressrelease/global-pain-management-drugs-devices.htm

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Each TMR syndicated research report covers a different sector - such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.

US Office Contact

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

Back To Top